Combination of anticholineric and β mimetics for the treatment of respiratory diseases

US7985766B2 · kind B2 · utility

Assignee

• MEDA PHARMA GMBH & CO. KG · DE

Inventors

• Joachim Goede · Hanau, DE
• Joachim Maus · Mühlheim, DE
• Peter Jurgen Cnota · Bad Homburg vor der Höhe, DE
• Istvan Szelenyi · Arnstorf, DE

Key dates

• Filing date: Jul 30, 2007
• Grant date: Jul 26, 2011
• Expiry date: Oct 19, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention describes a combination of an anticholinergic, such as R,R-glycopyrrolate, and a β mimetic, such as tormoterol, for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma.